Lower nucleolin expression was reported to be correlated with shorter overall survival of patients with stage II pancreatic ductal adenocarcinoma, 21 while in gastric cancer the overexpression of nucleolar nucleolin was found to be the only independent prognostic factor correlated with better prognosis (longer overall survival).22 The gene discussed is NUCLEOLIN; the disease is pancreatic ductal adenocarcinoma.